1. Humanisation and characterisation of PR1A3, a monoclonal antibody specific for cell-bound carcinoembryonic antigen

   • Lorna M. Stewart
   • Susan Young
   • David Snary

   ORIGINAL ARTICLE Pages: 299 - 306

2. Effect of local interleukin-2 treatment on spontaneous tumours of different immunogenic strength

   • Lucja Fiszer-Maliszewska
   • Willem Den Otter
   • Marian Mordarski

   ORIGINAL ARTICLE Pages: 307 - 314

3. Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma

   • Szilvia Mosolits
   • Ulrika Harmenberg
   • Håkan Mellstedt

   ORIGINAL ARTICLE Pages: 315 - 320

4. Kinetics of cellular trafficking and cytotoxicity of 9.2.27-gelonin immunotoxins targeted against the high-molecular-weight melanoma-associated antigen

   • Michael C. Chan
   • Regina M. Murphy

   ORIGINAL ARTICLE Pages: 321 - 329

5. Rejection of tumors of the B cell lineage by idiotype-vaccinated mice

   • Joseph Haimovich
   • Tova Kukulansky
   • Nurit Hollander

   ORIGINAL ARTICLE Pages: 330 - 336

6. Vaccination with the extracellular domain of p185 ^neu prevents mammary tumor development in neu transgenic mice

   • Laura J. Esserman
   • Theresa Lopez
   • Michael J. Campbell

   ORIGINAL ARTICLE Pages: 337 - 342

7. Comparison of simian virus 40 large T antigen recombinant protein and DNA immunization in the induction of protective immunity from experimental pulmonary metastasis

   • Allison M. Watts
   • Michael H. Shearer
   • Ronald C. Kennedy

   ORIGINAL ARTICLE Pages: 343 - 351

8. Cancer Vaccine Week, an international symposium 5–9 October 1998, New York, NY

   • Graham Pawelec

   SYMPOSIUM SERIES Pages: 352 - 356